CHARACTERISTICS AND MANAGEMENT OF MIGRAINE PATIENTS WHO HAVE FAILED PRIOR PREVENTIVE TREATMENT IN PORTUGAL

被引：0
|
作者：
Silva, C. [1 ]
Vo, P. [2 ]
Carboni, V [3 ]
Quintana, R. [4 ]
Monge, S. [1 ]
Laires, P. A. [1 ]
机构：
[1] Novartis Farma, Porto Salvo, Portugal
[2] Novartis Pharma AG, Basel, Switzerland
[3] GfK Hlth, Basel, Switzerland
[4] GfK, Madrid, Spain
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2106
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND141
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [1] Efficacy of fremanezumab in migraine patients who have failed at least one prior migraine preventive medication
    McAllister, Peter
    Dodick, David W.
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [2] Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication
    McAllister, Peter
    Dodick, David
    Cohen, Joshua
    Yang, Ronghua
    Yeung, Paul
    Campos, Verena Ramirez
    [J]. NEUROLOGY, 2019, 92 (15)
  • [3] Long-term efficacy of erenumab in patients with episodic migraine who have failed prior preventive migraine therapies
    Reuter, U.
    Schwedt, T.
    Kudrow, D.
    Paemeleire, K.
    Zhang, F.
    Klatt, J.
    Picard, H.
    Chou, D.
    Mikol, D. D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 637 - 637
  • [4] Long-term Efficacy of Erenumab in Patients With Episodic Migranie Who Have Failed Prior Preventive Migraine Therapies
    Reuter, Uwe
    Schwedt, Todd J.
    Kudrow, David
    Paemeleire, Koen
    Zhang, Feng
    Klatt, Jan
    Picard, Hernan
    Chou, Denise E.
    Mikol, Daniel D.
    [J]. NEUROLOGY, 2019, 92 (15)
  • [5] Impact of Fremanezumab on Response Rates, Migraine Days, and Acute Medication Use in Patients with Chronic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication
    Silberstein, Stephen
    Ailani, Jessica
    Cohen, Joshua
    Yang, Ronghua
    Yeung, Paul P.
    Campos, Verena Ramirez
    [J]. NEUROLOGY, 2019, 92 (15)
  • [6] Impact of fremanezumab on response rates, migraine days, and acute medication use in patients with chronic migraine who have failed at least one prior migraine preventive medication
    Silberstein, Stephen D.
    Ailani, Jessica
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [7] Health Care Utilization and Costs in Patients With Migraine Who Have Failed Previous Preventive Treatments
    Newman, Lawrence
    Vo, Pamela
    Zhou, Lujia
    Lopez, Cristina Lopez
    Cheadle, Andy
    Olson, Melvin
    Fang, Juanzhi
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (03) : 206 - 215
  • [8] Efficacy of fremanezumab in migraine patients who have failed at least one prior migraine preventive medication (vol 19, pg O40, 2018)
    McAllister, Peter
    Dodick, David W.
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [9] Impact of fremanezumab on response rates, acute medication use, and disability in patients with episodic migraine who have failed at least one prior migraine preventive medication
    Winner, Paul K.
    Singh, Rashmi B. Halker
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [10] Impact of Fremanezumab on Response Rates, Acute Medication Use, and Disability in Patients With Episodic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication
    Winner, Paul
    Singh, Rashmi Halker
    Cohen, Joshua
    Yang, Ronghua
    Yeung, Paul
    Campos, Verena Ramirez
    [J]. NEUROLOGY, 2019, 92 (15)
12345